Long-term effects of rapamycin treatment on insulin mediated phosphorylation of Akt/PKB and glycogen synthase activity

Experimental Cell Research

Volumn 314, Issue 6, 2008, Pages 1281-1291

  Varma, Shailly ^a   Shrivastav, Anuraag ^a,b   Changela, Sheena ^a   Khandelwal, Ramji L ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b SASKATCHEWAN CANCER AGENCY   (Canada)

Author keywords

Akt PKB phosphorylation; Glycogen synthase; HepG2 cells; Insulin; IRS 1; Protein phosphatase 1; Rapamycin

Indexed keywords

GLYCOGEN SYNTHASE; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; RAPAMYCIN; SERINE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING;

MAMMALIA;

EID: 40049086403     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.12.019     Document Type: Article

References (45)

1. B. Rubio-Viqueira M. Hidalgo Targeting mTOR for cancer treatment Adv. Exp. Med. Biol. 587 2006 309 327
2. E.K. Rowinsky Targeting the molecular target of rapamycin (mTOR) Curr. Opin. Oncol. 16 2004 564 575
3. T. Schmelzle M.N. Hall TOR, a central controller of cell growth Cell 103 2000 253 262
4. S. Isotani K. Hara C. Tokunaga H. Inoue J. Avruch K. Yonezawa Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro J. Biol. Chem. 274 1999 34493 34498
5. G.J. Brunn C.C. Hudson A. Sekulic J.M. Williams H. Hosoi P.J. Houghton J.C. Lawrence Jr. R.T. Abraham Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin Science 277 1997 99 101
6. D.H. Kim D.D. Sarbassov S.M. Ali J.E. King R.R. Latek H. Erdjument-Bromage P. Tempst D.M. Sabatini mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery Cell 110 2002 163 175
7. D.H. Kim D.D. Sarbassov S.M. Ali R.R. Latek K.V. Guntur H. Erdjument-Bromage P. Tempst D.M. Sabatini GβL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR Mol. Cell 11 2003 895 904
8. R. Loewith E. Jacinto S. Wullschleger A. Lorberg J.L. Crespo D. Bonenfant W. Oppliger P. Jenoe M.N. Hall Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control Mol. Cell 10 2002 457 468
9. D.D. Sarbassov S.M. Ali S. Sengupta J.H. Sheen P.P. Hsu A.F. Bagley A.L. Markhard D.M. Sabatini Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB Mol. Cell 22 2006 159 168
10. D.D. Sarbassov S.M. Ali D.H. Kim D.A. Guertin R.R. Latek H. Erdjument-Bromage P. Tempst D.M. Sabatini Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton Curr. Biol. 14 2004 1296 1302
11. Q. Yang K. Inoki T. Ikenoue K.L. Guan Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity Genes Dev. 20 2006 2820 2832
12. V. Hietakangas S.M. Cohen Re-evaluating AKT regulation: role of TOR complex 2 in tissue growth Genes Dev. 21 2007 632 637
13. E. Jacinto V. Facchinetti D. Liu N. Soto S. Wei S.Y. Jung Q. Huang J. Qin B. Su SIN1/MIP1 maintains rictor–mTOR complex integrity and regulates Akt phosphorylation and substrate specificity Cell 127 2006 125 137
14. D.D. Sarbassov D.A. Guertin S.M. Ali D.M. Sabatini Phosphorylation and regulation of Akt/PKB by the rictor–mTOR complex Science 307 2005 1098 1101
15. D.R. Alessi S.R. James C.P. Downes A.B. Holmes P.R. Gaffney C.B. Reese P. Cohen Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha Curr. Biol. 7 1997 261 269
16. L. Khamzina A. Veilleux S. Bergeron A. Marette Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance Endocrinology 146 2005 1473 1481
17. P.H. Scott G.J. Brunn A.D. Kohn R.A. Roth J.C. Lawrence Jr. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway Proc. Natl. Acad. Sci. 95 1998 7772 7777
18. A. Toker A.C. Newton Cellular signaling: pivoting around PDK-1 Cell 103 2000 185 188
19. J.R. Graff B.W. Konicek A.M. McNulty Z. Wang K. Houck S. Allen J.D. Paul A. Hbaiu R.G. Goode G.E. Sandusky R.L. Vessella B.L. Neubauer Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression J. Biol. Chem. 275 2000 24500 24505
20. A. Nesterov X. Lu M. Johnson G.J. Miller Y. Ivashchenko A.S. Kraft Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis J. Biol. Chem. 276 2001 10767 10774
21. D. Haas-Kogan N. Shalev M. Wong G. Mills G. Yount D. Stokoe Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC Curr. Biol. 8 1998 1195 1198
22. H.J. Lin F.C. Hsieh H. Song J. Lin Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer Br. J. Cancer 93 2005 1372 1381
23. O. Warburg On the origin of cancer cells Science 123 1956 309 314
24. D. Gupta N.A. Syed W.J. Roesler R.L. Khandelwal Effect of overexpression and nuclear translocation of constitutively active PKB-α on cellular survival and proliferation in HepG2 cells J. Cell. Biochem. 93 2004 513 525
25. J. Liu D.L. Brautigan Glycogen synthase association with the striated muscle glycogen-targeting subunit of protein phosphatase-1. Synthase activation involves scaffolding regulated by β-adrenergic signaling J. Biol. Chem. 275 2000 26074 26081
26. A. Takai G. Mieskes Inhibitory effect of okadaic acid on the p -nitrophenyl phosphate phosphatase activity of protein phosphatases Biochem. J. 275 Pt 1 1991 233 239
27. H. Towbin, T. Staehelin, J. Gordon, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979, Biotechnology 24 (1992) 145–149.
28. J.A. Thomas K.K. Schlender J. Larner Specificity of activation of glycogen synthase I from skeletal muscle and heart Biochim. Biophys. Acta 293 1973 84 93
29. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding Anal. Biochem. 72 1976 248 254
30. S. Varma R.L. Khandelwal Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB Biochim. Biophys. Acta 1770 2007 71 78
31. D.A. Cross P.W. Watt M. Shaw J. van der Kaay C.P. Downes J.C. Holder P. Cohen Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue FEBS Lett. 406 1997 211 215
32. M.J. Brady A.C. Nairn A.R. Saltiel The regulation of glycogen synthase by protein phosphatase 1 in 3T3-L1 adipocytes. Evidence for a potential role for DARPP-32 in insulin action J. Biol. Chem. 272 1997 29698 29703
33. N. Begum Stimulation of protein phosphatase-1 activity by insulin in rat adipocytes. Evaluation of the role of mitogen-activated protein kinase pathway J. Biol. Chem. 270 1995 709 714
34. Z. Zeng D. Sarbassov dos I.J. Samudio K.W. Yee M.F. Munsell C. Ellen Jackson F.J. Giles D.M. Sabatini M. Andreeff M. Konopleva Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML Blood 109 2007 3509 3512
35. S.Y. Sun L.M. Rosenberg X. Wang Z. Zhou P. Yue H. Fu F.R. Khuri Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition Cancer Res. 65 2005 7052 7058
36. S.B. Kudchodkar Y. Yu T.G. Maguire J.C. Alwine Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes Proc. Natl. Acad. Sci. U. S. A. 103 2006 14182 14187
37. L.R. Pearce X. Huang J. Boudeau R. Pawlowski S. Wullschleger M. Deak A.F. Ibrahim R. Gourlay M.A. Magnuson D.R. Alessi Identification of Protor as a novel rictor-binding component of mTOR complex-2 Biochem. J. 405 2007 513 522
38. S.Y. Woo D.H. Kim C.B. Jun Y.M. Kim E.V. Haar S.I. Lee J.W. Hegg S. Bandhakavi T.J. Griffin PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor β expression and signaling J. Biol. Chem. 282 2007 25604 25612
39. M.E. Cleasby T.A. Reinten G.J. Cooney D.E. James E.W. Kraegen Functional studies of Akt isoform specificity in skeletal muscle in vivo ; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression Mol. Endocrinol. 21 2007 215 228
40. M.J. Ernest K.H. Kim Regulation of rat liver glycogen synthetase. Evidence for a lysyl residue essential for glucose 6-phosphate activation J. Biol. Chem. 249 1974 6770 6778
41. S.D. Killilea H. Brandt E.Y. Lee W.J. Whelan Evidence for the coordinate control of activity of liver glycogen synthase and phosphorylase by a single protein phosphatase J. Biol. Chem. 251 1976 2363 2368
42. G.D. Van Duyne R.F. Standaert P.A. Karplus S.L. Schreiber J. Clardy Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin J. Mol. Biol. 229 1993 105 124
43. L. Pirola S. Bonnafous A.M. Johnston C. Chaussade F. Portis E. Van Obberghen Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells J. Biol. Chem. 278 2003 15641 15651
44. X. Wan B. Harkavy N. Shen P. Grohar L.J. Helman Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism Oncogene 2006
45. Y. Shi H. Yan P. Frost J. Gera A. Lichtenstein Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade Mol. Cancer Ther. 4 2005 1533 1540